Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Greig

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Cell and Developmental Biology|September 2, 2022
Disruption of the VAPB-PTPIP51 ER-mitochondria tethering proteins in post-mortem human amyotrophic lateral sclerosisNaomi Hartopp, Dawn H W Lau, Sandra M Martin-Guerrero, et al.
Cancer Research|April 2, 2017
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer ImmunotherapyDemin Li, Carol Bentley, Amanda Anderson, et al.
Molecular Cancer Therapeutics|August 10, 2019
Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer TherapyMassimo Masiero, Demin Li, Pat Whiteman, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Cell and Developmental Biology|September 2, 2022
Disruption of the VAPB-PTPIP51 ER-mitochondria tethering proteins in post-mortem human amyotrophic lateral sclerosisNaomi Hartopp, Dawn H W Lau, Sandra M Martin-Guerrero, et al.
Cancer Research|April 2, 2017
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer ImmunotherapyDemin Li, Carol Bentley, Amanda Anderson, et al.
Molecular Cancer Therapeutics|August 10, 2019
Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer TherapyMassimo Masiero, Demin Li, Pat Whiteman, et al.
Pageof 2